How to Make Money From Massive Volatility in the Cannabis Sector in 2020

Talking about volatility in investing is often a one-sided conversation. In other words, most people expect a stock to go up or down, but typically in one direction. With the Canadian cannabis industry, any investor who has seen a stock chart of the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) will know that volatility on both ends of the spectrum has…

Read More

3 Warning Signs for Cannabis Investors

Boy, what a year 2019 was for investors in Canada’s new cannabis industry. The mood among many has certainly shifted, and the euphoria with which companies were gobbling each other up has abated. Horizons Marijuana Life Sciences Index ETF is now down 65% from its 52-week high in early 2019 (not its overall peak). Questions about where the bottom is remain, and…

Read More

Why Canopy Growth (TSX:WEED) Stock Can Get Back All-Time Highs in 2020

The second phase of cannabis legalization in Canada, often called “Cannabis 2.0,” has reinvigorated many stocks in the sector over the last few months. Cannabis ETFs have gained momentum after being pummeled for most of 2019. Horizons Marijuana Life Sciences ETF has increased 7.6% over the past month as of close on January 16. Canopy Growth remains the biggest Canadian cannabis player. Shares…

Read More

This $520-Million Pot Stock Is Now Too Cheap to Ignore

Demand for legal pot continues to climb to new heights. Investment bank Cowen Inc has raised its 2030 sales forecast from $75 billion to $80 billion, only to bump it again to $85 billion last November. Globally, several analysts are now expecting sales to peak above $200 billion. If adjacent markets are any indication, even these rosy estimates could prove…

Read More

1 Way to Reduce Risk if You Want to Buy Cannabis Stocks

Uncertainty is back with a bang, as ratcheting Middle East tensions send risk through the roof only a few days into the new year. Oil is up, gold is up, and risky assets such as cannabis are down. The development in Iraq could see mounting unrest directly impacting the energy sector, with a knock-on effect for the broader international economy.…

Read More

Top Cannabis Stocks for December

Cannabis stocks have had a tough year. Since the summer, most marijuana ETFs have been cut in half. Yet the long-term promise remains clear. Many analysts expect global sales to hit $100 billion by 2030, representing 1,000% growth. If you want to invest in cannabis stocks, it pays to have a multi-year vision. Still, short-term market gyrations can make some…

Read More

HEXO’s (TSX:HEXO) Stock Rebound Could Be Legendary

HEXO (TSX:HEXO)(NYSE:HEXO) was once one of the hottest stocks in the emerging cannabis industry. In 2016, shares were priced at just $0.50. This May, they topped $10. The rise was incredible, but the recent cannabis bear market has hit the stock hard. Shares recently touched $2.50 apiece. To be fair, nearly every pot stock has been hit hard. Marijuana ETFs…

Read More

New Cannabis Data Proves Why This Market Is Still Heading Higher

The cannabis market has gone cold — or at least the stocks have. This year, most marijuana ETFs are down more than 50%. Stocks of both big and small companies alike have cratered. Nearly every competitor has been impacted. This type of contraction is commonplace in emerging markets. According to the Gartner hype cycle, a well-known tool for predicting the…

Read More

Layoffs, Licences, and Losses: Inside CannTrust’s (TSX:TRST) Horrible Year

CannTrust Holdings (TSX:TRST)(NYSE:CTST) has been one of the worst-performing cannabis stocks of 2019. Down 78% year to date, it has dramatically underperformed the Horizons Medical Marijuana Index ETF, which tracks the cannabis sector has a whole. CannTrust’s 2019 slide has been driven by a series of unfortunate events, some of which call into question the company’s ability to keep selling cannabis.…

Read More

Is Aurora Cannabis (TSX:ACB) Stock a Millionaire Maker?

Aurora Cannabis (TSX:ACB)(NYSE:ACB) has had a terrible run in 2019. Down 29% for the year, it has declined more than the Horizons Medical Marijuana Life Science ETF, which tracks the marijuana industry as a whole. Investors who bought ACB at the start of the year are probably not happy right now. However, with the stock cheaper than it has been in…

Read More